University Of Arkansas
Clinical trials sponsored by University Of Arkansas, explained in plain language.
-
New antibody combo aims to stop High-Risk myeloma in its tracks
Disease control Not yet recruitingThis study tests whether two bispecific antibodies (teclistamab and talquetamab) given in sequence can improve survival in 50 people with high-risk multiple myeloma. Participants will receive chemotherapy, immunotherapy, and possibly a stem cell transplant depending on how well t…
Phase: PHASE2 • Sponsor: University of Arkansas • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Could a measles vaccine fight pancreatic cancer? new trial aims to find out
Disease control Not yet recruitingThis early-phase study tests whether injecting the measles, mumps, and rubella (MMR) vaccine directly into pancreatic tumors is safe and can shrink them. About 20 adults with advanced, non-spreading pancreatic cancer that cannot be removed by surgery will receive the injection. R…
Phase: PHASE1, PHASE2 • Sponsor: University of Arkansas • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
AI boosts prostate cancer detection in men with tricky MRI scans
Diagnosis Not yet recruitingThis study tests whether an artificial intelligence (AI) algorithm can help doctors find prostate cancer more accurately during biopsies. It includes 50 men aged 40 and older who have unclear or low-risk MRI results but high PSA levels. Half will get an AI-guided biopsy, and the …
Phase: NA • Sponsor: University of Arkansas • Aim: Diagnosis
Last updated May 15, 2026 11:54 UTC
-
Amino acid boost may speed up spine surgery recovery
Symptom relief Not yet recruitingThis study tests whether taking essential amino acid supplements for two weeks before and three months after spinal surgery helps adults with spinal deformity recover better. Twenty participants will be randomly assigned to receive either the supplement or a placebo. The goal is …
Phase: NA • Sponsor: University of Arkansas • Aim: Symptom relief
Last updated May 17, 2026 03:29 UTC
-
Low-Dose naltrexone tested as fatigue fighter for prostate cancer patients
Symptom relief Not yet recruitingThis study tests whether a small daily dose of naltrexone (3 mg) can ease severe tiredness in men with prostate cancer who are on hormone therapy (ADT). Researchers will measure fatigue, inflammation, and quality of life in 60 participants. The goal is to find a safe, simple way …
Phase: PHASE2 • Sponsor: University of Arkansas • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC
-
Can training doctors save more lives from smoking and lung cancer?
Knowledge-focused Not yet recruitingThis study tests whether training healthcare providers can improve how they help patients quit smoking and get screened for lung cancer. About 300 doctors who treat smokers will take online training modules and answer surveys. The goal is to see if the training changes their know…
Phase: NA • Sponsor: University of Arkansas • Aim: Knowledge-focused
Last updated May 17, 2026 03:32 UTC
-
Telehealth Check-Ins for new moms: a simple way to catch problems early?
Knowledge-focused Not yet recruitingThis study tests whether three telehealth visits with a community health worker after childbirth can help new mothers complete their postpartum checkups and catch health problems earlier. About 500 women will be randomly assigned to either the CAREPATH program or standard care. T…
Phase: NA • Sponsor: University of Arkansas • Aim: Knowledge-focused
Last updated May 11, 2026 20:41 UTC